Cancer Research Communications: 2023, vol: , issue:
- 1)- Emily M Rencsok, Natalie Slopen, Hannah D McManus, Karen A Autio, Alicia K Morgans, Lawrence McSwain, Pedro Barata, Heather H Cheng, Robert Dreicer, Travis Gerke, Rebecca Green, Elisabeth I Heath, Lauren E Howard, Rana R McKay, Joel Nowak, Shannon Pileggi, Mark M Pomerantz, Dana E Rathkopf, Scott T Tagawa, Young E Whang, Camille Ragin, Folakemi T Odedina, Philip W Kantoff, Jake Vinson, Paul Villanti, Sebastien Haneuse, Lorelei A Mucci, Daniel J George. Pain and its association with survival for Black and White individuals with advanced prostate cancer in the US. Cancer research communications. 2023, 4 (1): 55-64
Cited : 3Read More - 2)- Dalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, Ching-Heng Chou, Clifford S Guy, Michaela Meehl, Zhongzhen Yi, Scott Perry, Jonathan Laxton, Trevor Cunningham, Deanna Langfitt, Peter Vogel, Christopher DeRenzo, Stephen Gottschalk, Martine F Roussel, Paul G Thomas, Giedre Krenciute. CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity. Cancer research communications. 2023, 3 (12): 2430-2446Cited : 4Read More
- 3)- Paul B Chapman, Mark Klang, Michael A Postow, Alexander Noor Shoushtari, Ryan J Sullivan, Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Phillip Wong, Margaret K Callahan, Bin Zheng, Jonathan Zippin. Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib. Cancer research communications. 2023, 3 (12): 2447-2454Cited : 1Read More
- 4)- Andrea R Daniel, Chang Su, Nerissa T Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R Selitsky, Jennifer L Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M Mowery, Diana M Cardona, Chang-Lung Lee, David G Kirsch. Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas. Cancer research communications. 2023, 3 (12): 2455-2467Cited : 0Read More
- 5)- Shadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, Margarita Raygada, Robin Lockridge, John W Glod, Crystal Flowers, B J Thomas, Donna B Bernstein, Oxana B Kapustina, Ashish Jain, Markku Miettinen, Mark Raffeld, Liqiang Xi, Manoj Tyagi, Jung Kim, Kenneth Aldape, Ashkan A Malayeri, Rosandra N Kaplan, Taryn Allen, Christina A Vivelo, Abby B Sandler, Brigitte C Widemann, Karlyne M Reilly, . Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants. Cancer research communications. 2023, 3 (12): 2468-2482Cited : 0Read More
- 6)- William Echavidre, Jérôme Durivault, Célia Gotorbe, Thays Blanchard, Marina Pagnuzzi, Valérie Vial, Florian Raes, Alexis Broisat, Rémy Villeneuve, Régis Amblard, Nicolas Garnier, Cécile Ortholan, Marc Faraggi, Benjamin Serrano, Vincent Picco, Christopher Montemagno. Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance. Cancer research communications. 2023, 3 (12): 2483-2496Cited : 1Read More
- 7)- Dennis Juarez, Roberta Buono, Shannon M Matulis, Vikas A Gupta, Madeleine Duong, Jacob Yudiono, Madhuri Paul, Sharmila Mallya, Grace Diep, Peter Hsin, Alexander Lu, Sang Mi Suh, Vy M Dong, Andrew W Roberts, Joel D Leverson, Muhammad Jalaluddin, Zhuangzhuang Liu, Orlando F Bueno, Lawrence H Boise, David A Fruman. Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors. Cancer research communications. 2023, 3 (12): 2497-2509Cited : 1Read More
- 8)- Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria S Higbie, Kanwal P S Raghav, Benny Johnson, Arvind Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Scott Kopetz, Michael J Overman, Van Karlyle Morris. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications. 2023, 3 (12): 2510-2517Cited : 2Read More
- 9)- Debarshi Banerjee, Shuobo Boboila, Shunpei Okochi, James M Angelastro, Angela V Kadenhe-Chiweshe, Gonzalo Lopez, Andrea Califano, Eileen P Connolly, Lloyd A Greene, Darrell J Yamashiro. Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. Cancer research communications. 2023, 3 (12): 2518-2530Cited : 2Read More
- 10)- Emanuela Gentile, Andrew W Hahn, Jian H Song, Anh Hoang, Peter D A Shepherd, Sumankalai Ramachandran, Nora M Navone, Eleni Efstathiou, Mark Titus, Paul G Corn, Sue-Hwa Lin, Christopher J Logothetis, Theocharis Panaretakis. Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer. Cancer research communications. 2023, 3 (12): 2531-2543Cited : 1Read More
- 11)- Raymond W Hughley, Marco Matejcic, Ziwei Song, Xin Sheng, Peggy Wan, Lucy Xia, Steven N Hart, Chunling Hu, Siddhartha Yadav, Alexander Lubmawa, Vicky Kiddu, Frank Asiimwe, Colline Amanya, George Mutema, Kuteesa Job, Mbaaga K Ssebakumba, Sue A Ingles, Ann S Hamilton, Fergus J Couch, Stephen Watya, David V Conti, Burcu F Darst, Christopher A Haiman. Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry. Cancer research communications. 2023, 3 (12): 2544-2550Cited : 0Read More
- 12)- Vikram Malhi, Priya Agarwal, Mary R Gates, Lichuan Liu, Jianshuang Wang, Tom De Bruyn, Scott Lam, Jennifer Eng-Wong, Pablo Perez-Moreno, Ya-Chi Chen, Jiajie Yu. Optimizing Early-stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast Cancer. Cancer research communications. 2023, 3 (12): 2551-2559Cited : 2Read More
- 13)- Tarek H Mouhieddine, Chidimma Nzerem, Robert Redd, Andrew Dunford, Matthew Leventhal, Romanos Sklavenitis-Pistofidis, Sabrin Tahri, Habib El-Khoury, David P Steensma, Benjamin L Ebert, Robert J Soiffer, Jonathan J Keats, Shaadi Mehr, Daniel Auclair, Irene M Ghobrial, Adam S Sperling, Chip Stewart, Gad Getz. Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma. Cancer research communications. 2023, 3 (12): 2560-2571Cited : 2Read More
- 14)- Pamela Munster, Nicholas Iannotti, Daniel C Cho, John M Kirkwood, Liza C Villaruz, Geoffrey T Gibney, F Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day. Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications. 2023, 3 (12): 2572-2584Cited : 3Read More
- 15)- Ferdynand J Kos, Paul Frankel, Mihaela Cristea, Melissa Eng, Raechelle Tinsley, Shannon Dempsey, Nora Ruel, Daphne Stewart, Thanh H Dellinger, Don J Diamond. Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer. Cancer research communications. 2023, 3 (12): 2585-2595Cited : 1Read More
- 16)- Siobhan O'Brien, Tajinder Ubhi, Lucie Wolf, Krishna Gandhi, Sichun Lin, Naz Chaudary, Neesha C Dhani, Michael Milosevic, Grant W Brown, Stephane Angers. FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe. Cancer research communications. 2023, 3 (12): 2596-2607Cited : 3Read More
- 17)- Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, Michael Ohh, Mehdi Layeghifard, Adam Shlien, Madeline N Hayes, Meredith S Irwin. SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma. Cancer research communications. 2023, 3 (12): 2608-2622Cited : 0Read More
- 18)- Aslamuzzaman Kazi, Alok Ranjan, Vasantha Kumar M V, Bogos Agianian, Martin Garcia Chavez, Vignesh Vudatha, Rui Wang, Rajanikanth Vangipurapu, Liwei Chen, Perry Kennedy, Karthikeyan Subramanian, Jonathan C K Quirke, Francisca Beato, Patrick W Underwood, Jason B Fleming, Jose Trevino, Paul J Hergenrother, Evripidis Gavathiotis, Said M Sebti. Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors. Cancer research communications. 2023, 3 (12): 2623-2639Cited : 2Read More
- 19)- Denada Dibra, Mihai Gagea, Yuan Qi, Gilda P Chau, Xiaoping Su, Guillermina Lozano. p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis. Cancer research communications. 2023, 3 (12): 2640-2652Cited : 0Read More
- 20)- Ruiliang Wang, Qiufan Xu, Hanxu Guo, Guanjie Yang, Jun Zhang, Hong Wang, Tianyuan Xu, Changcheng Guo, Jing Yuan, Yanyan He, Xiaoying Zhang, Hongliang Fu, Guang Xu, Binghui Zhao, Jun Xie, Tingting Zhao, Longfei Huang, Jiansheng Zhang, Bo Peng, Xudong Yao, Bin Yang. Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer. Cancer research communications. 2023, 3 (11): 2221-2232Cited : 1Read More
- 21)- Wei Tang, Flora Zhang, Jung S Byun, Tiffany H Dorsey, Harris G Yfantis, Anuoluwapo Ajao, Huaitian Liu, Margaret S Pichardo, Catherine M Pichardo, Alexandra R Harris, Xiaohong R Yang, Jonine D Figueroa, Shahin Sayed, Francis W Makokha, Stefan Ambs. Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients. Cancer research communications. 2023, 3 (11): 2244-2255Cited : 1Read More
- 22)- Melanie M Frigault, Arushi Mithal, Harvey Wong, Beatrix Stelte-Ludwig, Vinay Mandava, Xin Huang, Joseph Birkett, Amy J Johnson, Raquel Izumi, Ahmed Hamdy. Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription. Cancer research communications. 2023, 3 (11): 2268-2279Cited : 1Read More
- 23)- Jun Nakayama, Yusuke Yamamoto. Cancer-prone Phenotypes and Gene Expression Heterogeneity at Single-cell Resolution in Cigarette-smoking Lungs. Cancer research communications. 2023, 3 (11): 2280-2291Cited : 1Read More
- 24)- Henriette C Jodal, Eddymurphy U Akwiwu, Margriet Lemmens, Pien M Delis-van Diemen, Dagmar Klotz, Leticia G Leon, Soufyan Lakbir, Meike de Wit, Remond J A Fijneman, Monique E van Leerdam, Evelien Dekker, Manon C W Spaander, Gerrit A Meijer, Magnus Løberg, Veerle M H Coupé, Mette Kalager, Beatriz Carvalho. Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study. Cancer research communications. 2023, 3 (11): 2292-2301Cited : 0Read More
- 25)- Tomoyuki Satake, Shunsuke Kondo, Noriko Tanabe, Takaaki Mizuno, Yuki Katsuya, Jun Sato, Takafumi Koyama, Tatsuya Yoshida, Makoto Hirata, Noboru Yamamoto. Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients. Cancer research communications. 2023, 3 (11): 2302-2311Cited : 0Read More
- 26)- Felicia Gomez, Bryan Fisk, Joshua F McMichael, Matthew Mosior, Jennifer A Foltz, Zachary L Skidmore, Eric J Duncavage, Christopher A Miller, Haley Abel, Yi-Shan Li, David A Russler-Germain, Kilannin Krysiak, Marcus P Watkins, Cody A Ramirez, Alina Schmidt, Fernanda Martins Rodrigues, Lee Trani, Ajay Khanna, Julia A Wagner, Robert S Fulton, Catrina C Fronick, Michelle D O'Laughlin, Timothy Schappe, Amanda F Cashen, Neha Mehta-Shah, Brad S Kahl, Jason Walker, Nancy L Bartlett, Malachi Griffith, To. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. Cancer research communications. 2023, 3 (11): 2312-2330Cited : 4Read More
- 27)- Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O McDonald, Rinath Jeselsohn, Franziska Michor. Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor-positive Breast Cancer. Cancer research communications. 2023, 3 (11): 2331-2344Cited : 3Read More
- 28)- Alice Newey, Lu Yu, Louise J Barber, Jyoti S Choudhary, Michal Bassani-Sternberg, Marco Gerlinger. Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ. Cancer research communications. 2023, 3 (11): 2345-2357Cited : 0Read More
- 29)- Priyanka Chaudhary, Xia Xu, Guangfang Wang, Jacob P Hoj, Rishi R Rampersad, Marie-Liesse Asselin-Labat, Stephanie Ting, William Kim, Pablo Tamayo, Ann Marie Pendergast, Mark W Onaitis. Activation of KrasG12D in Subset of Alveolar Type II Cells Enhances Cellular Plasticity in Lung Adenocarcinoma. Cancer research communications. 2023, 3 (11): 2400-2411Cited : 0Read More
- 30)- Beiyuan Liang, Evan H Zhang, Zhen Ye, Hayden Storts, Wei Jin, Xinru Zheng, Hannah Hylton, Olivia Zaleski, Xuanxuan Xing, Wayne Miles, Jing J Wang. SIX4 Controls Anti-PD-1 Efficacy by Regulating STING Expression. Cancer research communications. 2023, 3 (11): 2412-2419Cited : 3Read More
- 31)- Emma Guyonnet, Shana J Kim, Yue Yin Xia, Vasily Giannakeas, Jan Lubinski, Susan Randall Armel, Andrea Eisen, Louise Bordeleau, Charis Eng, Olufunmilayo I Olopade, Nadine Tung, William D Foulkes, Fergus J Couch, Amber M Aeilts, Steven A Narod, Joanne Kotsopoulos. Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation. Cancer research communications. 2023, 3 (11): 2420-2429Cited : 0Read More
- 32)- Halley M Oyer, Alexandra R Steck, Charles G Longen, Sanjana Venkat, Konuralp Bayrak, Eleanor B Munger, Dan Fu, Paola A Castagnino, Christina M Sanders, Nathalia A Tancler, My T Mai, Justin P Myers, Matthew J Schiewer, Nan Chen, Elahe A Mostaghel, Felix J Kim. Sigma1 Regulates Lipid Droplet-mediated Redox Homeostasis Required for Prostate Cancer Proliferation. Cancer research communications. 2023, 3 (10): 2195-2210Cited : 0Read More
- 33)- Annabelle Nwaokorie, Walter Kolch, Dirk Fey. A Systems Biology Approach to Understand the Racial Disparities in Colorectal Cancer. Cancer research communications. 2023, : Cited : 0Read More
- 34)- Emily Schwarz, Brooke Benner, Lianbo Yu, Fode Tounkara, William E Carson. Analysis of changes in plasma cytokine levels in response to interleukin 12 therapy in three clinical trials. Cancer research communications. 2023, : Cited : 0Read More
- 35)- Oluwademilade O Dairo, Lia DePaula Oliveira, Ethan Schaffer, Thiago Vidotto, Adrianna A A Mendes, Jiayun Lu, Sophie Vo Huynh, Jessica L Hicks, Adam G Sowalsky, Angelo M De Marzo, Corinne E Joshu, Brian Hanratty, Karen S Sfanos, William B Isaacs, Michael C Haffner, Tamara L Lotan. FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-Genomic Features of Prostate Cancer. Cancer research communications. 2023, : Cited : 0Read More
- 36)- Ann Von Holle, Rachel L Thompson, Katie M O'Brien, Dale P Sandler, Clarice R Weinberg. Associations between Serum Iron Biomarkers and Breast Cancer Tumor Size. Cancer research communications. 2023, : Cited : 0Read More
- 37)- Joseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson, Fabian R Villagomez, Shaymaa Bahnassy, Steffi Oesterreich, Junxiao Hu, Zeynep Madak-Erdogan, Rebecca B Riggins, Bradley R Corr, Linda S Cook, Lindsey S Treviño, Benjamin G Bitler, Matthew J Sikora. WNT4 regulates cellular metabolism via intracellular activity at the mitochondria in breast and gynecologic cancers. Cancer research communications. 2023, : Cited : 2Read More
- 38)- Marta Ligero, Garazi Serna, Omar S M El Nahhas, Irene Sansano, Siarhei Mauchanski, Cristina Viaplana, Julien Calderaro, Rodrigo A Toledo, Rodrigo Dienstmann, Rami S Vanguri, Jennifer L Sauter, Francisco Sanchez-Vega, Sohrab P Shah, Santiago Ramón Y Cajal, Elena Garralda, Paolo Nuciforo, Raquel Perez-Lopez, Jakob Nikolas Kather. Weakly supervised deep learning predicts immunotherapy response in solid tumors based on PD-L1 expression. Cancer research communications. 2023, : Cited : 4Read More
- 39)- Vivek Subbiah, Niamh Coleman, Sarina A Piha-Paul, Apostolia M Tsimberidou, Filip Janku, Jordi Rodon, Shubham Pant, Ecaterina E Dumbrava, Siqing Fu, David S Hong, Shizhen Zhang, Ming Sun, Yunfang Jiang, Jason Roszik, Juhee Song, Ying Yuan, Funda Meric-Bernstam, Aung Naing. Phase I study of mTORC1/2 inhibitor sapanisertib in combination with metformin in patients with mTOR/AKT/PI3K pathway alterations and advanced solid malignancies. Cancer research communications. 2023, : Cited : 5Read More
- 40)- David C Klein, Santana M Lardo, Sarah J Hainer. The ncBAF complex regulates transcription in AML through H3K27ac sensing by BRD9. Cancer research communications. 2023, : Cited : 1Read More
- 41)- Maxim De Schepper, Ha-Linh Nguyen, François Richard, Louise Rosias, Florence Lerebours, Roman Vion, Florian Clatot, Anca Berghian, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Chiara Molinelli, Matteo Lambertini, Federica Grillo, Gabriele Zoppoli, Luc Dirix, Kevin Punie, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Patrick Neven, Anne Vincent-Salomon, Denis Larsimont, Caroline Duhem, Patrice Viens, François Bertucci, Elia Biganzoli, Peter Vermeulen, Giuseppe Floris, Christine Desmedt. Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer research communications. 2023, : Cited : 0Read More
- 42)- Emma Saulters, Paul T Kennedy, Rachel J Carter, Abdullah Alsufyani, Terence M Jones, John F Woolley, Lekh N Dahal. Differential Regulation of the Stimulator of Interferon Genes pathway in Human Papillomavirus positive and negative Head and Neck Cancers. Cancer research communications. 2023, : Cited : 3Read More
